Liu Allen, Vosshenrich Christian A J, Lagresle-Peyrou Chantal, Malassis-Seris Michele, Hue Christophe, Fischer Alain, Di Santo James P, Cavazzana-Calvo Marina
Développement normal et pathologique du système immunitaire, Institut National de la Santé et de la Recherche Médicale U768-Site Necker-Enfants Malades, Paris Cedex 15, France.
Blood. 2006 Aug 15;108(4):1123-8. doi: 10.1182/blood-2006-01-0061. Epub 2006 Apr 13.
Severe combined immunodeficiency (SCID) is characterized by a complete block in T-lymphocyte differentiation. Most SCID also affects B-cell development or function, although a normal pool of pro-B cells is detectable. Treatment of SCID consists of allogeneic hematopoietic stem cell transplantation (HSCT), but in the absence of a myeloablative conditioning regimen, only T cells, and in some cases, natural killer (NK) cells, are of donor origin, while all other leukocytes subsets are of host origin. We hypothesized that donor B-cell development success could be conditioned by the competitive ability of recipient B-cell precursors in the bone marrow. We therefore compared the outcome of unconditioned HSCT in mice that differed with respect to their pro-B-cell compartments. B-cell reconstitution was limited in recipient mice containing a normal pro-B-cell pool, whereas immature and mature B-cell numbers reached wild-type levels in mice with compromised early B-cell precursors. Interestingly, host NK cells did not modify the outcome of unconditioned HSCT as long as the early B-cell compartment was compromised. These observations suggest that recipient B-cell precursors condition the reconstitution of the donor B-cell pool and, if extrapolative to humans, suggest that conditioning regimens targeting host pro-B cells may help improve B-cell reconstitution after allogeneic HSCT.
重症联合免疫缺陷(SCID)的特征是T淋巴细胞分化完全受阻。大多数SCID也会影响B细胞的发育或功能,尽管可以检测到正常的前B细胞池。SCID的治疗包括异基因造血干细胞移植(HSCT),但在没有清髓预处理方案的情况下,只有T细胞,在某些情况下还有自然杀伤(NK)细胞是供体来源,而所有其他白细胞亚群都是宿主来源。我们假设供体B细胞的发育成功可能受骨髓中受体B细胞前体竞争能力的影响。因此,我们比较了前B细胞区室不同的小鼠未经预处理的HSCT结果。在含有正常前B细胞池的受体小鼠中,B细胞重建受到限制,而在早期B细胞前体受损的小鼠中,未成熟和成熟B细胞数量达到野生型水平。有趣的是,只要早期B细胞区室受损,宿主NK细胞就不会改变未经预处理的HSCT结果。这些观察结果表明,受体B细胞前体决定了供体B细胞池的重建,如果外推到人类,表明针对宿主前B细胞的预处理方案可能有助于改善异基因HSCT后的B细胞重建。